News Releases

New vaccine protects against two of the most common swine diseases, while offering animal-friendly and efficient administration through IDAL® device technology Rahway, NJ, Sept. 25, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the  European Medicines Agency has granted the marketing authorization in the […]

Read more

First centrally registered vaccine in the European Union against the currently circulating avian influenza virus strains of clade 2.3.4.4b RAHWAY, N.J., May 24, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Commission has granted the marketing authorization for the INNOVAX®-ND-H5 vaccine for […]

Read more